Bone marrow inhibition induced by azathioprine in a patient without mutation in the thiopurine S-methyltransferase pathogenic site: A case report

Figure 2 Routine blood work. The ‘baseline’ time point is the initiation of azathioprine therapy. Four weeks after azathioprine therapy was stopped, all values returned to their baseline levels. A: Changes in the white blood cell count. The increase in the white blood cell count after azathioprine therapy was stopped was caused by the injection of filgrastim; B: Changes in hemoglobin; C: Changes in the platelet count.